ROCO
6527
Market cap62mUSD
Nov 12, Last price
82.40TWD
Name
Crystalvue Medical Corp
Chart & Performance
P/E
15.33
P/S
2.25
EPS
5.38
Div Yield, %
2.50%
Shrs. gr., 5y
—
Rev. gr., 5y
7.30%
Revenues
868m
+5.35%
Net income
127m
+22.98%
CFO
153m
-0.62%
Dividend
Jul 11, 20242.06363 TWD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Crystalvue Medical Corporation designs, manufactures, and sells ophthalmic medical equipment worldwide. The company offers retinal cameras, tonometers, lens edgers, and gastroenterology supplies. Crystalvue Medical Corporation was founded in 2009 and is based in Taoyuan City, Taiwan.
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||